Page 8 - Rgene Technologies News Today

EQS-Adhoc: Lonza Group AG: Lonza Publishes Restated Financials for 2020 Lonza Publishes Restated Financials for 2020 29-Jun-2021 / 07:01 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Lonza reports restated 2020 financials for sales, EBIT, EBITDA and CORE EBITDA Lonza now provides 2020 financials in the redesigned business structure to reflect divisional performance Basel, Switzerland, 29 June 2021 - Prio...

/PRNewswire/ -- American Gene Technologies (AGT), a clinical-stage biotechnology company, announced treatment of the first participant in its Phase I clinical...

Plus: Company hits milestone in development of 'HIV functional cure'; Milt Peterson, legendary developer, dies

Search jobs 03-May-2021 Nucleic Acid Labeling Market Size 2021-Segmentation and Analysis by Latest Trends, Share, Development and Growth by Regions to 2027 The global Nucleic Acid Labeling Market research report, published by DBMR, is designed to offer various market frameworks such as market size, portion, trends, growth path, value and factors that impact the current market dynamics over the forecast period 2021-2027. Most importantly, this report...

ResearchAndMarkets.com’s offering. Exosome-related technologies have been developing rapidly over the past few years and substantial growth is expected for the market as they get integrated into the fields of liquid biopsy, precision medicine and regenerative medicine. In particular, cancer derived exosomes influence the invasive potential of cells by regulating angiogenesis, metastasis, and immunity, making them an extremely useful source of biomarkers for use in cancer detection, diagnosis,...

LGBT+ Investment Firm Gaingels Joins American Gene Technologies Mission to Cure HIV, and Other Serious Human Diseases News provided by Share this article , an emerging gene and cell therapy company, announced today that Gaingels, a leading venture investment syndicate in service of the LGBT+ community and its allies, made an investment in AGT to support the Phase 1 clinical trial of an HIV cure. The Phase 1 human trial is investigating the safety of AGT103-T, a single dose, autologous cell the...

Search jobs 01-Apr-2021 Global CRISPR and CRISPR-associated (Cas) Genes Market to 2026 with Profiles of OriGene Technologies, Thermo Fisher Scientific, Takara Bio, Horizon Discovery, Addgene and More - ResearchAndMarkets.com ResearchAndMarkets.coms offering. The CRISPR and CRISPR-associated (Cas) Genes Market was estimated to be USD 1,563.52 million in 2020 and is poised to grow at a CAGR of 15.67% to reach USD 3,733.66 million by the year 2026. The ...

Published: Mar 12, 2021 Lonza to Commission a Dedicated Suite for Clinical and Commercial Supply of Altimmune’s COVID-19 Vaccine Candidate at its Houston Facility GAITHERSBURG, Md. and BASEL, Switzerland, March 12, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it has expanded its previously-announced AdCOVID manufacturing collaboration with Lonza. Under the expanded agreement, Lonza will commission a dedicated man...

Share this article Share this article ResearchAndMarkets.coms offering. The Global Biochip Market is expected to grow at an impressive rate of around 15% during the forecast period. The Global Biochip Market is driven by the growing prevalence of various chronic and infectious disease especially in the geriatric population who are more susceptible to these diseases on account of low immunity. This has led to the increase in the demand for personalized medicine solutions or targeted therapies e...

 size is expected to reach USD 7.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.1% from 2021 to 2028. Technological advancements in viral vectors, a growing pipeline of advanced therapies, and a rising number of regulatory approvals for advance therapy products are some key driving forces of the market. Key suggestions from the report: The wide implementation of biological gene delivery technologies in clinical usage...